Agilent Technologies, Inc. (A)
A Price and Sentiment
A Latest news
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
2021-10-21 08:31SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has received CE-IVD mark approval for the PD-L1 IHC 28-8 pharmDx to guide options for the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal cancers. Gastric (stomach) cancer is the fifth most common cancer and the fourth leading cause of cancer death worldwide, with over 1,000,000 new cases and approximately 770,000 deaths
ETFs to Ride on a Solid Start to Q3 Earnings
2021-10-20 11:40The rounds of upbeat earnings has set the stage for the S&P 500 Index to hit new highs as more Q3 earnings unfold.
5 Best Performing Stocks of the S&P 500 ETF Last Week
2021-10-18 16:42The S&P 500 Index wrapped up its best week since July, climbing 1.8% on encouraging quarterly earnings releases from several companies
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
2021-10-13 16:16SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered. This is the first IHC assay measuring Ki-67 expression to receive FDA approval in the context of treatment with Verzenio and was de
Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)
2021-09-28 08:00SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced Professor Bernhard Lendl has been selected to receive a prestigious Agilent Thought Leader Award. Highly renowned in the field of vibrational spectroscopy, Dr. Lendl is a professor at the TU Wien (Vienna) and head of the working group on Process Analysis & Vibrational Spectroscopy at the institution. Professor Lendl's work focuses on adapting powerful spectroscopic techniques and unique combinations of
Dividend Champion And Contender Highlights: Week Of September 26
2021-09-26 02:57A weekly summary of dividend activity for Dividend Champions and Contenders.
Dr. Mikael Dolsten Named to Agilent Board of Directors
2021-09-23 16:05SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Pfizer executive Dr. Mikael Dolsten appointed to Agilent board of directors.
Agilent Announces Cash Dividend of 19.4 Cents per Share
2021-09-22 16:05SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces dividend.
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
2021-09-17 10:42Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Investing in Water ETFs
2021-09-16 13:33An in-depth look at the leading water ETFs in the U.S stock market.